Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Last Updated: June 25, 2022

Actavis Labs Fl Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS FL, and what generic and branded alternatives to ACTAVIS LABS FL drugs are available?

ACTAVIS LABS FL has seventy-two approved drugs.

There are five tentative approvals on ACTAVIS LABS FL drugs.

Summary for Actavis Labs Fl

US Patents:	0
Tradenames:	58
Ingredients:	56
NDAs:	72

Drugs and US Patents for Actavis Labs Fl

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Labs Fl Inc	METFORMIN HYDROCHLORIDE	metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	203755-001	Aug 1, 2016	AB3	RX	No	No		See Plans and Pricing				See Plans and Pricing
Actavis Labs Fl Inc	ALPRAZOLAM	alprazolam	TABLET, EXTENDED RELEASE;ORAL	077198-002	May 13, 2010		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Actavis Labs Fl Inc	FLUTAMIDE	flutamide	CAPSULE;ORAL	075820-001	Sep 18, 2001		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Actavis Labs Fl	METHYLPHENIDATE HYDROCHLORIDE	methylphenidate hydrochloride	TABLET, EXTENDED RELEASE;ORAL	076772-001	Mar 22, 2018	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Actavis Labs Fl Inc	BUPROPION HYDROCHLORIDE	bupropion hydrochloride	TABLET, EXTENDED RELEASE;ORAL	079094-001	Mar 24, 2009	AB2	RX	No	Yes		See Plans and Pricing				See Plans and Pricing
Actavis Labs Fl Inc	TAZTIA XT	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	075401-005	Apr 10, 2003	AB4	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for ACTAVIS LABS FL drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic

Express Scripts

Moodys

Mallinckrodt

McKesson

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.